MENOPAUSE
Do You Need an Early Menopause Test?
When early menopause becomes a clinical consideration, what blood tests can and cannot tell you, and why proper assessment matters more than a single result.
When women search for an early menopause test, they are usually asking one of two questions: whether menopause may be starting earlier than expected, or whether a blood test can confirm what is happening. Both are reasonable questions, and both deserve a clear clinical answer. The difficulty is that menopause testing is not as straightforward as many patients expect — a single blood test rarely provides a definitive answer, particularly during perimenopause when hormone levels fluctuate unpredictably.
That does not mean testing is pointless. It means testing needs to be interpreted in context, and clinical assessment usually provides more useful information than a result in isolation. For the broader menopause and treatment overview, see menopause and HRT.
ON THIS PAGE
When early menopause becomes a consideration
Menopause is considered early when it occurs before age 45 and premature when it occurs before 40 (premature ovarian insufficiency). A GP may consider the possibility where periods change significantly earlier than expected, particularly when cycle disruption is accompanied by vasomotor symptoms such as hot flushes and night sweats, sleep disturbance, mood change, anxiety, vaginal dryness, or reduced libido. A proper review takes account of age, menstrual history, the full symptom picture, medication, previous hormone use, family history of early menopause, and whether another cause should also be considered.
What blood tests can and cannot tell you
FSH (follicle-stimulating hormone) and oestradiol are the tests most commonly associated with menopause diagnosis, but their reliability depends on context. In women over 45 with typical menopausal symptoms, blood tests are usually unnecessary — the diagnosis is clinical. In women under 40 with suspected premature ovarian insufficiency, FSH testing is more relevant and may need to be repeated to confirm a sustained elevation. Between 40 and 45, the clinical picture may be less clear, and testing can sometimes help clarify the situation. The important point is that a single FSH result in perimenopause can fluctuate significantly and should not be used alone to confirm or exclude the diagnosis.
Other investigations — including thyroid function tests, full blood count, and vitamin D — may also be useful where fatigue, mood change, or weight disturbance are prominent, to exclude alternative or coexisting causes.
Assessment
Why clinical assessment matters more than a number
A GP consultation can clarify what approach is most appropriate for your situation. This includes reviewing the symptom pattern, considering whether the presentation fits a menopausal picture, determining whether blood tests would add useful information, and discussing what the results would mean in context. For patients under 40, testing is more clinically relevant and may need repeating. For patients over 45 with typical symptoms, starting treatment based on clinical assessment alone is usually appropriate.
The aim is to avoid both unnecessary testing and unnecessary delay in treatment.
Same-day appointments available. Book online or call 020 7736 7557.
Why early menopause matters clinically
If menopause is confirmed before age 45, there are implications beyond symptom management. Earlier loss of oestrogen is associated with increased risks to bone density and cardiovascular health over time. Current guidance generally recommends that women with early menopause take HRT at least until the average age of natural menopause (around 51), primarily for bone and cardiovascular protection rather than symptom relief alone. This is an important clinical conversation and another reason why assessment matters rather than relying on a home test or a single laboratory result.
Next steps
What may happen after assessment
Depending on the presentation, the next step may involve reassurance, broader menopause discussion and treatment planning, hormone testing where indicated, consideration of HRT for both symptom relief and long-term protection, or referral to a specialist menopause service where the situation is complex.
A 30-minute women’s health appointment at Basuto gives time to review your symptoms properly, consider what investigation is appropriate, and discuss treatment options in a way that makes clinical sense for your individual situation.
Frequently asked questions
At what age is menopause considered early?
Menopause before age 45 is considered early. Before age 40, it is classified as premature ovarian insufficiency (POI). Both warrant clinical assessment, and treatment is usually recommended at least until the average age of natural menopause for bone and cardiovascular protection.
Can I test for menopause at home?
Home FSH kits are available but have limited clinical reliability. A single FSH reading can fluctuate significantly during perimenopause and may produce both false positives and false negatives. Clinical assessment — considering your age, symptoms, cycle history and medical background — provides substantially more useful information than a home test result alone.
Should I see a GP even if my symptoms are mild?
If you are under 45 and suspect early menopause, assessment is worthwhile regardless of symptom severity. Early recognition allows discussion about bone and cardiovascular protection as well as symptom management. If symptoms are affecting quality of life, work, mood, sleep or relationships at any age, it is reasonable to seek advice.
FURTHER READING